Metraipolis › archive › dc_eab5cefa870d

Trends in Pseudomonas aeruginosa In Vitro Susceptibility to Ceftolozane/Tazobactam in Latin America: SMART Surveillance Program, 2016-2024 — Europe PMC PMID:41148710

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41148710
DOI
10.3390/antibiotics14101018
License (as archived)
solo-consultazione
Archived
2026-11-09T07:39:48.050Z
SHA-256 of the archived text
1b8f49acb9112cb37a51bd41c49ff4c60c951c5b06ac939fc43711f81fea863b
Stable URL of this page
https://metraipolis.com/documento/dc_eab5cefa870d

How to cite

Trends in Pseudomonas aeruginosa In Vitro Susceptibility to Ceftolozane/Tazobactam in Latin America: SMART Surveillance Program, 2016-2024 — Europe PMC PMID:41148710 — Europe PMC (en), https://europepmc.org/article/MED/41148710 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eab5cefa870d (Metraipolis archive dc_eab5cefa870d, sha256 1b8f49acb9112cb37a51bd41c49ff4c60c951c5b06ac939fc43711f81fea863b)
BibTeX
@misc{dceab5cefa870d,
  title = {Trends in Pseudomonas aeruginosa In Vitro Susceptibility to Ceftolozane/Tazobactam in Latin America: SMART Surveillance Program, 2016-2024 — Europe PMC PMID:41148710},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41148710},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eab5cefa870d; sha256 1b8f49acb9112cb37a51bd41c49ff4c60c951c5b06ac939fc43711f81fea863b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41148710. Agents can read the archived copy with the MCP tool read_document.